Absorption, distribution, metabolism and excretion of corifollitropin alfa, a recombinant hormone with a sustained follicle-stimulating activity

Pharmacology

Volumn 85, Issue 2, 2010, Pages 77-87

  Van Schanke, A ^a   Van De Wetering Krebbers, S F M ^a   Bos, E ^a   Sloot, W N ^a  

^a Schering Plough ^*  (Netherlands)

Author keywords

Carboxy terminal peptide, of subunit of human chorionic gonadotropin; Chorionic gonadotropin; Recombinant human follicle stimulating hormone

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; CHORIONIC GONADOTROPIN BETA SUBUNIT; CORIFOLLITROPIN ALPHA; DRUG METABOLITE; FOLLITROPIN BETA SUBUNIT; IODINE 125; MELANIN; RECOMBINANT HORMONE; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION; FOLLICLE STIMULATING HORMONE, HUMAN, WITH HCG C-TERMINAL PEPTIDE; FOLLITROPIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATABOLISM; CONTROLLED STUDY; DEIODINATION; DRUG ABSORPTION; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG SPECIFICITY; FECES ANALYSIS; FEMALE; KIDNEY PARENCHYMA; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RADIATION DETECTION; RADIOMETRY; RAT; SINGLE DRUG DOSE; TISSUE DISTRIBUTION; URINALYSIS; ABSORPTION; AMINO ACID SEQUENCE; ANIMAL; BLOOD; CHO CELL LINE; COMPARATIVE STUDY; CRICETULUS; DELAYED RELEASE FORMULATION; HAMSTER; HUMAN; METABOLISM; MOLECULAR GENETICS; OVARY FOLLICLE; PHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; URINE; WISTAR RAT;

ABSORPTION; AMINO ACID SEQUENCE; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; DELAYED-ACTION PREPARATIONS; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; INJECTIONS, SUBCUTANEOUS; MOLECULAR SEQUENCE DATA; OVARIAN FOLLICLE; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TISSUE DISTRIBUTION;

EID: 75149114684     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000276546     Document Type: Article

References (42)

1. Fares FA, Suganuma N, Nishimori K, LaPolt PS, Hsueh AJ, Boime I: Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit. Proc Natl Acad Sci USA 1992;89:4304-4308.
2. Beckers NG, Macklon NS, Devroey P, Platteau P, Boerrigter PJ, Fauser BC: First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization. Fertil Steril 2003;79:621-623.
3. Gordon K: New developments in gonadotrophin pharmacology. Reprod Biomed Online 2002;5:259-264.
4. The Corifollitropin Alfa Dose Finding Study Group: A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation. Hum Reprod 2008;23:2484-2492.
5. Bouloux PM, Handelsman DJ, Jockenhovel F, Nieschlag E, Rabinovici J, Frasa WL, de Bie JJ, Voortman G, Itskovitz-Eldor J: First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males. Hum Reprod 2001;16:1592-1597.
6. Matzuk MM, Hsueh AJ, Lapolt P, Tsafriri A, Keene JL, Boime I: The biological role of the carboxyl-terminal extension of human chorionic gonadotropin beta-subunit. Endocrinology 1990;126:376-383.
7. Bishop LA, Nguyen TV, Schofield PR: Both of the beta-subunit carbohydrate residues of follicle-stimulating hormone determine the metabolic clearance rate and in vivo potency. Endocrinology 1995;136:2635-2640.
8. Creus S, Chaia Z, Pellizzari EH, Cigorraga SB, Ulloa-Aguirre A, Campo S: Human FSH isoforms: carbohydrate complexity as determinant of in vitro bioactivity. Mol Cell Endocrinol 2001;174:41-49.
9. de Leeuw R, Mulders J, Voortman G, Rombout F, Damm J, Kloosterboer L: Structure-function relationship of recombinant follicle-stimulating hormone (Puregon). Mol Hum Reprod 1996;2:361-369.
10. Kalyan NK, Bahl OP: Role of carbohydrate in human chorionic gonadotropin: effect of deglycosylation on the subunit interaction and on its in vitro and in vivo biological properties. J Biol Chem 1983;258:67-74.
11. Baenziger JU: Glycosylation: to what end for the glycoprotein hormones? Endocrinology 1996;137:1520-1522.
12. 4-4GalNAcβ1, 4GlcNAcβ1,2Manα that mediates rapid clearance of lutropin. Cell 1991;67:1103-1110.
13. 4 receptor. Proc Natl Acad Sci USA 2000;97:9949-9954.
14. x types in addition to the sulfated N-glycans of lutropin. J Exp Med 2000;191:1117-1126.
15. Gay VL: Decreased metabolism and increased serum concentrations of LH and FSH following nephrectomy of the rat: absence of short-loop regulatory mechanisms. Endocrinology 1974;95:1582-1588.
16. 123I-scintigraphic imaging in rats explains its short circulatory half-life. Reprod Biol Endocrinol 2003;1:64.
17. Devroey P, Fauser BC, Platteau P, Beckers NG, Dhont M, Mannaerts BM: Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 2004;89:2062-2070.
18. Duijkers IJ, Klipping C, Boerrigter PJ, Machielsen CS, de Bie JJ, Voortman G: Single-dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females. Hum Reprod 2002;17:1987-1993.
19. Emmanouel DS, Stavropoulos T, Katz AI: Role of the kidney in metabolism of gonadotropins in rats. Am J Physiol 1984;247:E786-E792.
20. Nisula BC, Blithe DL, Akar A, Lefort G, Wehmann RE: Metabolic fate of human choriogonadotropin. J Steroid Biochem 1989;33:733-737.
21. Sebok K, Sairam MR, Cantin M, Mohapatra SK: Distribution of follitropin and deglycosylated follitropin in the rat: a quantitative and radioautographic study. Mol Cell Endocrinol 1987;52:185-197.
22. Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D: Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int 1979;16:251-270.
23. Ulloa-Aguirre A, Timossi C, Mian-Matsumura P, Dias JA: Role of glycosylation in function of follicle-stimulating hormone. Endocrine 1999;11:205-215.
24. Birken S, Berger P, Bidart JM, Weber M, Bristow A, Norman R, Sturgeon C, Stenman UH: Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites. Clin Chem 2003;49:144-154.
25. van Ravestein A, de Leeuw R, Mulders J, van der Vorstenbosch C, Voortman G, Rombout F: Fate of recombinant human FSH after intravenous administration to female Wistar rats. Eur J Endocrinol 1994;130:214.
26. Birken S, Kovalevskaya G, O'Connor J: Metabolism of hCG and hLH to multiple urinary forms. Mol Cell Endocrinol 1996;125:121-131.
27. Elliott MM, Kardana A, Lustbader JW, Cole LA: Carbohydrate and peptide structure of the alpha- and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine 1997;7:15-32.
28. Fiddes JC, Goodman HM: The gene encoding the common alpha subunit of the four human glycoprotein hormones. J Mol Appl Genet 1981;1:3-18.
29. 125I-containing acylating agent. Biochem J 1973;133:529-539.
30. Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP: Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 1997;13:407-484.
31. 125I-human growth hormone in vivo: relevance to the study of protein disposition. Biochem Pharmacol 1991;42:889-897.
32. 125I-labelled follicle-stimulating hormone. J Endocrinol 1973;58:275-287.
33. Sanford JC, Batten BE: Endocytosis of follicle-stimulating hormone by ovarian granulosa cells: analysis of hormone processing and receptor dynamics. J Cell Physiol 1989;138:154-164.
34. 125I]iodochorionic gonadotropin from the circulation in the rat: tissue uptake and degradation. Endocrinology 1979;104:1540-1547.
35. Markkanen SO, Rajaniemi HJ: Uptake and subcellular catabolism of human choriogonadotropin in the proximal tubule cells of rat kidney. Mol Cell Endocrinol 1979;13:181-190.
36. 125I-labeled gonadotropins in mouse. Acta Pharmacol Toxicol 1977;41:101-103.
37. Rajaniemi H, Vanha-Perttula T: Specific receptor for LH in the ovary: evidence by autoradiography and tissue fractionation. Endocrinology 1972;90:1-9.
38. Beitins IZ, Derfel RL, O'Loughlin K, McArthur JW: Immunoreactive luteinizing hormone, follicle-stimulating hormone and their subunits in human urine following gel filtration. J Clin Endocrinol Metab 1977;44:149-159.
39. Bristow A, Berger P, Bidart JM, Birken S, Norman R, Stenman UH, Sturgeon C: Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin. Clin Chem 2005;51:177-182.
40. Stenman UH, Tiitinen A, Alfthan H, Valmu L: The classification, functions and clinical use of different isoforms of hCG. Hum Reprod Update 2006;12:769-784.
41. Szkudlinski MW, Thotakura NR, Tropea JE, Grossmann M, Weintraub BD: Asparagine-linked oligosaccharide structures determine clearance and organ distribution of pituitary and recombinant thyrotropin. Endocrinology 1995;136:3325-3330.
42. Holdsworth S, Atkins RC, de Kretser DM: The pituitary-testicular axis in men with chronic renal failure. N Engl J Med 1977;296:1245-1249.